Contribution of genetic variations in estradiol biosynthesis and metabolism enzymes to osteoporosis

Acta Pharmacologica Sinica

Volumn 21, Issue 7, 2000, Pages 587-590

  Cheng, Ze Neng ^a   Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

17beta HSD; CYP19; CYP1A2; CYP3A4; Estradiol; Osteoporosis

Indexed keywords

CYTOCHROME P450 3A4; ESTRADIOL; PRASTERONE;

BONE METABOLISM; CATALYSIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME METABOLISM; ESTROGEN SYNTHESIS; GENETIC VARIABILITY; HORMONE RESPONSE; HYDROXYLATION; OSTEOPOROSIS; POSTMENOPAUSE; REVIEW;

ANIMALS; AROMATASE; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL; HUMANS; HYDROXYSTEROID DEHYDROGENASES; MIXED FUNCTION OXYGENASES; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0033942732     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Nawata H, Tanaka S, Tanaka S, Takayanagi R, Sakai Y, Yanase T, et al. Aromatase in bone cells: association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 1995; 53: 165-74.
2. Jakob F, Siggelkow H, Homann D, Kohrle J, Adamski J, Schutze N. Local estradiol metabolism in osteoblast and osteoclast-like cells. J Steroid Biochem Mol Biol 1997; 61: 167-74.
3. Shozu M, Zhao Y, Bulun SE, Simpson ER. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter 1.6. Endocrinology 1998; 139: 1610-7.
4. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80: 3689-98.
5. Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D, Lu Q, et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab 1998; 83: 1348-57.
6. Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Borresen-Dale AL. A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 1998; 8: 43-8.
7. Dumont M, Luu-The V, de Launoit Y, Labrie F. Expression of human 17β-hdroxysteroid dehydrogenase in mammalian cells. J Steroid Biochem Mol Biol 1992; 41: 605-8.
8. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S. Expression cloning and characterization of human 17-β-hdroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteriod dehydrogenase activity. J Biol Chem 1993; 268: 12961-9.
9. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, et al. Male pseudohermaphroditism cause by mutation of testicular 17-β-hdroxysteroid dehydrogenase 3. Nat Genet 1994; 7: 34-9.
10. Adamski J, Normand T, Leenders F, Monte D, Begue A, Stehelin D, et al. Molecular cloning of a novel widely expressed human 80 kDa 17-β-hdroxysteroid dehydrogenase 4. Biochem J 1995; 322: 437-43.
11. El-Alfy M, Luu-The V, Huang XF, Berger L, Labrie F, Pelletier G. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology 1999; 140: 1481-91.
12. Normand T, Narod S, Labrie F, Simard J. Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase H gene at the EDH17B2 locus on 17q11-q21. Hum Mol Genet 1993; 2: 479-83.
13. Leenders F, Dolez V, Begue A, Moller G, Gloeckner JC, de Launoit Y, et al. Structure of the gene for the human 17beta-hydroxysteroid dehydrogenase types IV. Mamm Genome 1998; 9: 1036-41.
14. de Launoit Y, Adamski J. Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome. J Mol Endocrinol 1999; 22: 227-40.
15. Dong Y, Qiu QQ, Debear J, Lathrop WF, Bertolini DR, Tamburini PP. 17Beta-hydroxysteroid dehydrogenase in human bone cells. J Bone Miner Res 1998; 13: 1539-46.
16. Hammond DK, Zhu BT, Wang MY. Cytochrome P450 metabolism of estradiol in hamster liver and kidney. Toxicol Appl Pharmacol 1997; 145: 51-60.
17. Aoyama T, Korzekwa K, Nagata K, Gillette J, Gelboin HV, Gonzalez FJ. Estradiol metabolism by complementary deoxyribonucleic acid expressed human Cytochrome P450. Endocrinology 1990; 126: 3101-6.
18. Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, et al. Determination of CYP1A2 and NAT2 Phenotypes in Human Population by Analysis of Caffeine Urinary Metabolites. Pharmacogenetics 1992; 2: 116-27.
19. Ouyan DS, Huang SL, Wang W, Xie HG, Xu ZH, Zhou HH. Phenotypic polymorphism and gender-related difference of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol 2000; 49: 145-51.
20. Huang JD, Guo WC, Lai MD, Guo YL, Lambert GH. Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. Drug Metab Dispos 1999; 27: 98-101.
21. Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo) 1999; 125: 803-8.
22. Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C→ A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999; 47: 445-9.
23. Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 1998; 90: 1225-9.
24. Westlind A, Lofberg L, Tindberg N, Andersson TB, Ingelman-Sundberg M. Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region. Biochem Biophys Res Commun 1999; 259: 201-5.
25. Michnovicz JJ, Glbraith RA. Cimetidine Inhibits Catechol Estrogen Metabolism in Women. Metab Clin Exp 1991; 40: 170-4.